Literature DB >> 27815659

In Vitro Antifungal Susceptibility of Neoscytalidium dimidiatum Clinical Isolates from Malaysia.

Jasper Elvin James1, Jacinta Santhanam2, Mei Chen Lee1, Choon Xian Wong1, Parameswari Sabaratnam3, Hamidah Yusoff4, Mohd Nizam Tzar4, Mohd Fuat Abdul Razak3.   

Abstract

Neoscytalidium dimidiatum is an opportunistic fungus causing cutaneous infections mostly, which are difficult to treat due to antifungal resistance. In Malaysia, N. dimidiatum is associated with skin and nail infections, especially in the elderly. These infections may be mistaken for dermatophyte infections due to similar clinical appearance. In this study, Neoscytalidium isolates from cutaneous specimens, identified using morphological and molecular methods (28 Neoscytalidium dimidiatum and 1 Neoscytalidium sp.), were evaluated for susceptibility towards antifungal agents using the CLSI broth microdilution (M38-A2) and Etest methods. Amphotericin B, voriconazole, miconazole and clotrimazole showed high in vitro activity against all isolates with MIC ranging from 0.0313 to 1 µg/mL. Susceptibility towards fluconazole and itraconazole was noted in up to 10% of isolates, while ketoconazole was inactive against all isolates. Clinical breakpoints for antifungal drugs are not yet available for most filamentous fungi, including Neoscytalidium species. However, the results indicate that clinical isolates of N. dimidiatum in Malaysia were sensitive towards miconazole, clotrimazole, voriconazole and amphotericin B, in vitro.

Entities:  

Keywords:  Antifungal susceptibility; Malaysia; Neoscytalidium dimidiatum

Mesh:

Substances:

Year:  2016        PMID: 27815659     DOI: 10.1007/s11046-016-0085-5

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  42 in total

1.  Molecular taxonomy and GC/MS of metabolites of Scytalidium hyalinum and Nattrassia mangiferae (Hendersonula toruloidea).

Authors:  H J Roeijmans; G S De Hoog; C S Tan; M J Figge
Journal:  J Med Vet Mycol       Date:  1997 May-Jun

2.  Onychomycosis in Malaysia.

Authors:  K P Ng; T L Saw; M Madasamy; T Soo Hoo
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

3.  E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method.

Authors:  Ana Espinel-Ingroff; A Rezusta
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

4.  Case report. Nattrassia mangiferae endophthalmitis.

Authors:  Tawanda Gumbo; Ndodini Mkanganwi; Valerie J Robertson; Praise Masvaire
Journal:  Mycoses       Date:  2002-04       Impact factor: 4.377

5.  Mycoses in Thailand: current concerns.

Authors:  Rataporn Ungpakorn
Journal:  Nihon Ishinkin Gakkai Zasshi       Date:  2005

6.  Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin.

Authors:  David van Duin; Arturo Casadevall; Joshua D Nosanchuk
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

7.  European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe.

Authors:  A M Tortorano; A Prigitano; M C Esposto; V Arsic Arsenijevic; J Kolarovic; D Ivanovic; L Paripovic; L Klingspor; I Nordøy; P Hamal; S Arikan Akdagli; C Ossi; A Grancini; C Cavanna; G Lo Cascio; C Scarparo; A Candoni; M Caira; M Drogari Apiranthitou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-03       Impact factor: 3.267

8.  In vitro susceptibility of filamentous fungi to itraconazole, voriconazole and posaconazole by Clinical and Laboratory Standards Institute reference method and E-test.

Authors:  N Kondori; E Svensson; I Mattsby-Baltzer
Journal:  Mycoses       Date:  2010-06-14       Impact factor: 4.377

Review 9.  Invasive Nattrassia mangiferae infections: case report, literature review, and therapeutic and taxonomic appraisal.

Authors:  L Sigler; R C Summerbell; L Poole; M Wieden; D A Sutton; M G Rinaldi; M Aguirre; G W Estes; J N Galgiani
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

10.  In vitro activity of amphotericin B, itraconazole, voriconazole, posaconazole, caspofungin and terbinafine against Scytalidium dimidiatum and Scytalidium hyalinum clinical isolates.

Authors:  Claire Lacroix; Martine Feuilhade de Chauvin
Journal:  J Antimicrob Chemother       Date:  2008-01-24       Impact factor: 5.790

View more
  1 in total

1.  Deep Cutaneous Neoscytalidium dimidiatum Infection: Successful Outcome with Amphotericin B Therapy.

Authors:  Shih-Jyun Yang; Chau-Yee Ng; Ting-Shu Wu; Po-Yen Huang; Yen-Mu Wu; Pei-Lun Sun
Journal:  Mycopathologia       Date:  2018-12-05       Impact factor: 2.574

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.